Rebecca L. Forand is a journalist who writes for Healio, a platform that provides healthcare professionals with the latest news and information in their respective fields. Rebecca's articles focus on various dermatological topics, including the efficacy of different treatments for skin conditions, genetic markers for cancer, and advancements in melanoma detection.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Rebecca L. Forand predominantly covers healthcare and scientific topics, focusing on dermatology, skin conditions, psoriasis, and melanoma. Her articles often cite data and include expert commentary.
Given her focus on healthcare and scientific topics related to dermatology and skin conditions, she may be interested in receiving pitches from medical professionals or researchers with expertise in these areas who can provide insights into new treatment options, emerging research findings, or clinical trial results.
Pitches that offer access to exclusive data or studies related to dermatological treatments or the epidemiology of skin conditions might also be well received by Rebecca.
Since she doesn't have a specific geographic focus mentioned, it is important for sources to present information relevant at an international level within the realm of healthcare and pharmaceuticals.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Rebecca L. Forand, James Fernandez Md
CLEVELAND — For patients with chronic spontaneous urticaria, lab testing can help to phenotype disease and guide treatment, according to James Fernandez, MD, PhD, an allergy and immunology specialist at the Cleveland Clinic.In this video perspective from the Medical Dermatology Therapy Update III meeting, Fernandez highlights some of the treatment options currently available to these
By: Elaine Husni, Rebecca L. Forand, Kristen Dowd
CLEVELAND — Dermatology and rheumatology often work together in the treatment of psoriasis and psoriatic arthritis.
By: Rebecca L. Forand, Kristen Dowd
Isotretinoin is generally effective and well tolerated for acne treatment in patients receiving masculinizing gender-affirming care, but barriers can impede treatment success, according to a study.
By: Rebecca L. Forand, Kristen Dowd
Skin manifestations are common in VEXAS syndrome and evaluating their presentations can assist in genotyping the disease and possibly lead to better diagnoses, according to a study.
The TheraClearX Acne device was efficacious in reducing mild to moderate acne in all skin types, according to a study. “There are over 50 million acne patients domestically. Clinical solutions for acne include topical and systemic medication, as well as treatment by energy-based devices,” Glynis Ablon, MD, associate clinical professor at University of California, Los Angeles, director
By: Rebecca L. Forand, Kristen Dowd
Prior radiotherapy was associated with progression-free survival in patients with metastatic cutaneous squamous cell carcinoma treated with cemiplimab, according to a study.
Key takeaways: A strongly increased risk for malignant melanoma was found in patients with rosacea.
Patients with psoriasis treated with higher doses of oral zasocitinib experienced greater improvement than those treated with placebo, according to a phase 2b study.
By: Kristen Dowd, Rebecca L. Forand
Seborrheic dermatitis is more prevalent across the world than previously believed, with a global pooled prevalence of 4.38%, according to a comprehensive meta-analysis.
By: Rebecca L. Forand, Kristen Dowd
Patients with acne who used benzoyl peroxide products did not have a risk for malignancy or increased blood benzene levels, according to a pair of studies published in the Journal of the American Academy of Dermatology
(833) 317-6278 
